something is wrong, page-2

Hey spike , I see your point , I would be interested to see who is doing the selling . They said they had a buyer identified for the psoriasis treatment . Some more info on that may help . More positive results from the cancer trial would not hurt either . I think the trial results are a certainty . What I think you have is a drug that can easily get enough response rate to pass FDA approval guidelines (15%+) with its necrosis/apoptosis effect , that carries the vaccine effect along with it without having to wait for the long drawn out vaccine survival time trials .